STAT5 has also been implicated in IL-8 induction of tumor survival, chemotherapeutic resistance, and metastasis in breast cancer [121], with IL-8 expression in the TME known to drive TAM and neutrophil recruitment [123], further engendering an immune suppressive niche. Here, CXCL8 is linked to breast cancer.